Compare SLGL & PEBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SLGL | PEBK |
|---|---|---|
| Founded | 1997 | 1912 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 254.1M | 230.2M |
| IPO Year | 2016 | 2012 |
| Metric | SLGL | PEBK |
|---|---|---|
| Price | $63.06 | $43.78 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $110.00 | N/A |
| AVG Volume (30 Days) | ★ 52.7K | 16.0K |
| Earning Date | 05-22-2026 | 04-20-2026 |
| Dividend Yield | N/A | ★ 2.58% |
| EPS Growth | N/A | ★ 21.48 |
| EPS | N/A | ★ 1.76 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $223.84 | N/A |
| P/E Ratio | ★ N/A | $24.72 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $27.00 | $27.33 |
| 52 Week High | $97.97 | $45.78 |
| Indicator | SLGL | PEBK |
|---|---|---|
| Relative Strength Index (RSI) | 45.68 | 48.00 |
| Support Level | $62.21 | $41.53 |
| Resistance Level | $67.85 | $45.43 |
| Average True Range (ATR) | 3.08 | 0.92 |
| MACD | 0.11 | -0.10 |
| Stochastic Oscillator | 58.87 | 39.35 |
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted. It generates the majority of its revenue from the United States.
Peoples Bancorp of North Carolina Inc is a bank holding company. It is a state-chartered commercial bank serving Lincolnton, Newton, Denver, Catawba, Conover, Maiden, Claremont, Hiddenite, Hickory, Charlotte, Cornelius, Raleigh and Cary, North Carolina. It has a diversified loan portfolio with no foreign loans and few agricultural loans. The company's main source of income is dividends declared and paid by the Bank on its capital stock.